As Indian drug manufacturers cry foul over the surge of cheap Chinese pharmaceutical raw material imports, the Indian ...

Japan’s Eisai and US biotech major Biogen have announced that the latest findings demonstrating the benefits of continuous ...

US pharma major AbbVie is considering a $1-billion acquisition of Gilgamesh Pharmaceuticals, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Ipsen (Euronext: IPN) has reported second-quarter sales of 901 million euros ($980 million), up 8% from the same period a ...

UCB, Belgium’s largest drugmaker, today released financial results for first half 2025, showing total revenue in increased to ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...

Swedish biotech Oncopeptides (Nasdaq Stockholm: ONCO) has entered into a partnership with Spanish pharmaceutical broker SD ...

GSK (LSE: GSK) posted a 6% rise in second-quarter sales to £8 billion ($10.7 billion), ahead of analyst forecasts. Pre-tax ...

US biopharma Viridian Therapeutics has entered into an exclusive collaboration and license agreement with Japanese firm Kissei Pharmaceutical (TYO: 4547) to develop and commercialize veligrotug and ...

Vinay Prasad has left his post at the US Food and Drug Administration (FDA) less than three months after joining the agency.

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.